REVIVION
LIVE

Serial Number

99886336

Owner

PetVivo Holdings, Inc.

Attorney

Courtney Thompson

Filing Date

Jun 15, 2026

Add to watchlist:

No watchlists yet
View on USPTO

REVIVION Trademark

Serial Number: 99886336

REVIVION is a trademark filed by PetVivo Holdings, Inc. on June 15, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

PetVivo Holdings, Inc. (3 trademarks)

12100 Singletree Lane, Suite 186
Eden Prairie, MN 55344

Entity Type: 03

Trademark Details

Filing Date

June 15, 2026

Registration Date

Not Registered

Goods & Services

Biomaterials derived from natural components, and biomaterials comprised of naturally derived and synthetic materials, namely, hydrogels, microparticles, particulates, fibers, sheets, plugs, threads, scaffolds, matrices, membranes, patches, films, carrier materials, electroactive materials, piezoelectric materials, and composite biomaterials for medical and veterinary purposes, namely, for tissue repair, tissue remodeling, tissue restoration, tissue engineering, wound care, soft tissue augmentation, cartilage repair, orthopedic joint preservation, cardiovascular treatment, treatment of musculoskeletal disorders, pain reduction, cosmetic and aesthetic applications, and the delivery, controlled release, localization, or administration of pharmaceuticals, biologics, therapeutic agents, cells, proteins, peptides, growth factors, nucleic acids, and other bioactive substances.

Medical and veterinary devices, namely, injectable and implantable medical devices, implants, scaffolds, cellular matrix scaffolds, matrices, membranes, patches, films, sheets, plugs, threads, fibers, and carrier materials for tissue repair, tissue remodeling, tissue restoration, tissue engineering, wound healing, soft tissue augmentation, cartilage repair, orthopedic joint preservation, cardiovascular treatment, treatment of musculoskeletal disorders, pain reduction, cosmetic and aesthetic applications, and the delivery, controlled release, localization, or administration of pharmaceuticals, biologics, therapeutic agents, cells, proteins, peptides, growth factors, nucleic acids, and other bioactive substances; medical implants made of artificial materials for supporting, reinforcing, augmenting, repairing, replacing, remodeling, restoring, or regenerating tissue and anatomical structures; electroactive and piezoelectric medical devices for biostimulation, tissue stimulation, tissue repair, tissue remodeling, tissue restoration, wound healing, cartilage repair, orthopedic treatment, cardiovascular treatment, and tissue engineering applications.

Filing History

APPLICATION FILING RECEIPT MAILED
Jun 15, 2026 MAFR
NEW APPLICATION ENTERED
Jun 15, 2026 NWAP